Abstract
Psychological trauma has profound effects on brain function and precipitates psychiatric disorders in vulnerable individuals, however, the molecular mechanisms linking trauma with psychiatric risk remain incompletely understood. Using RNA-seq data postmortem brain tissue of a cohort of 304 donors (N=136 with trauma exposure), we investigated transcriptional signatures of trauma exposures in two cortical regions (dorsolateral prefrontal cortex, and dorsal anterior cingulate cortex) and two amygdala regions (medial amygdala and basolateral amygdala) associated with stress processing and regulation. We focused on dissecting heterogeneity of traumatic experiences in these transcriptional signatures by investigating exposure to several trauma types (childhood, adulthood, complex, single acute, combat, and interpersonal traumas) and interactions with sex. Overall, amygdala regions were more vulnerable to childhood traumas, whereas cortical regions were more vulnerable to adulthood trauma (regardless of childhood experience). Using cell-type-specific expression imputation, we identified a strong transcriptional response of medial amygdala excitatory neurons to childhood trauma, which coincided with dysregulation observed in a human induced pluripotent stem cell (hiPSC)-derived glutamatergic neurons exposed to hydrocortisone. We resolved multiscale coexpression networks for each brain region and identified modules enriched in trauma signatures and whose connectivity was altered with trauma. Trauma-associated coexpression modules provide insight into coordinated functional dysregulation with different traumas and point to potential gene targets for further dissection. Together, these data provide a characterization of the long-lasting human encoding of traumatic experiences in corticolimbic regions of human brain.
INTRODUCTION
There is a powerful link between trauma and mental health; traumatic stress is a major precipitating factor in the development of several psychiatric disorders, particularly mood and anxiety disorders, such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). Yet, the molecular mechanisms linking traumatic stress to psychiatric disorder risk are only beginning to be elucidated1–3. Traumatic experiences are processed through corticolimbic circuits4 and mount a whole body-endocrine response through glucocorticoid (GC) signaling5,6. Both circuit and endocrine systems employ robust negative feedback mechanisms to return the organism to homeostasis, however, dysfunction in these mechanisms, for example, undermodulation of limbic circuits by prefrontal cortex7 and GC hyper-/hypo-sensitivity8 precipitate prolonged psychiatric symptoms such as intrusions, avoidance, altered mood or arousal as a consequence.
It is critical to examine the contexts in which traumas occur. Since corticolimbic stress circuitry is molded in childhood and adolescence through critical periods of rapid synaptic growth, pruning and myelination9–11, trauma during development has lasting effects of emotional and cognitive processing12–14, and leads to a greater risk for psychiatric disorder in adulthood12. Different trauma types are also associated with differential risk for PTSD15. We and others have shown that different types of traumas predispose to disorder at different rates; for example, sexual traumas and childhood traumas are associated with increased rates of post-traumatic stress disorder (PTSD) compared to other traumas, even in the context of exposure to combat trauma or disasters16–18. Moreover, exposure to traumatic stress likely has different outcomes according to sex and gender, through a myriad of mechanisms both psychosocial (e.g., access to social support, stigmatization, and exposure to different types of traumas) and physiological (e.g., through interaction between stress hormones and reproductive hormones such as estradiol19,20).
Recent transcriptional studies of human postmortem brain have demonstrated transcriptomic dysregulation characteristics of traumatic stress-related psychiatric disorders in both a brain region- and cell type-specific manner, highlighting the importance of corticolimbic regions and several cell types21–27. Where human postmortem brain samples capture the breadth of lived experiences, cultured neurons derived from human-induced pluripotent stem cells (hiPSCs) isolate cell type specific effects of exposure in a naïve state. With this model, we have previously characterized a robust transcriptional response of hiPSC-derived glutamatergic neurons to hydrocortisone (HCort) 28. Evidence suggests that trauma-exposed patients with psychiatric symptoms may represent a distinct subtype of disorder (aside from PTSD, for which trauma exposure is a requirement) 13,29. We hypothesize that trauma per se produces a lasting transcriptional “scar” that is agnostic of diagnosis. To date, no published studies have examined the transcriptomic impacts of psychosocial trauma, and dissected how the encoding of various types of traumas accumulate in the human brain.
In this study, we investigate the lasting transcriptional encoding of trauma in the human dorsolateral prefrontal cortex (DLPFC), dorsal anterior cingulate cortex (dACC), and medial amygdala (MeA) and basolateral amygdala (BLA) in a large cohort of postmortem human brain samples of individuals with extensive trauma history phenotyping. We first characterize the transcriptional signatures and coexpression relationships of exposure to and accumulation of trauma throughout the lifespan in a brain region- and cell type-specific manner. Next, we explore several dimensions of trauma, including developmental period, trauma type, and trauma load, and highlight convergent and divergent mechanisms in their transcriptional signatures. Using hiPSC-derived excitatory neurons, we explore convergent transcriptional dysregulation across childhood trauma and hydrocortisone. Finally, we identify sex-specific gene expression interactions and investigate potential mechanisms underlying sex differences (e.g., trauma type, neuronal sex hormone interactions).
METHODS
Human postmortem cohort
Human autopsy brain tissue samples from 304 individuals were donated at time of autopsy through U.S. medical examiners’ office and from the VA National PTSD Brain Bank and Traumatic Stress Brain Research group. Psychiatric histories and demographic information were obtained by postmortem psychological autopsies conducted by clinicians with informants best acquainted with the individual and diagnostic review of medical records. Sex was defined as sex assigned at birth: 115 total donors were female, 189 were male. Race was assigned by clinician during psychological autopsy: donors represented a mix of White, Black and Hispanic. Mean age of death for all donors was 46.75 years. A full description of sample processing and sequencing can be found elsewhere23.
Trauma phenotyping
We catalogued each recorded lifetime traumatic exposure by literature-derived trauma categories (combat vs interpersonal traumas) and age group at which the traumatic event occurred: childhood (<20 y) or adulthood (>20y). Trauma histories were coded in three independent replicates (by 3 independent researchers) to reach a consensus coding for each donor. Each donor was assigned one value or category for each trauma variable (Table 1) and summarized across the cohort demographics (Table 2).
Table 1:
Trauma Variable | Trauma Variable Category | Description |
---|---|---|
TraumaAny | Any trauma | At least one trauma exposure |
No trauma | 0 reported lifetime traumas | |
Trauma Count | NA | Cumulative number of trauma exposures |
Childhood Adulthood | Childhood only | At least one reported trauma in childhood (<20 years old) and 0 reported adulthood ( 20+ years old) traumas |
Adulthood only | 0 reported traumas in childhood (<20 years old) and at least one reported adulthood ( 20+ years old) trauma | |
Both | At least one reported trauma in childhood (<20 years old) and at least reported trauma in adulthood ( 20+ years old) | |
No trauma | 0 reported lifetime traumas | |
Childhood Count | NA | Cumulative number of trauma exposures in childhood |
Adulthood Count | NA | Cumulative number of trauma exposures in adulthood |
Single Complex | Single only | At least one reported acute trauma (e.g. accident, assault) and 0 reported complex traumas (e.g. physical abuse, sexual abuse, neglect) |
Complex only | 0 reported acute traumas (e.g. accident, assault) and at least one reported complex traumas (e.g. physical abuse, sexual abuse, neglect) | |
Both | At least one reported acute trauma (e.g. accident, assault) and at least one reported complex trauma (e.g. physical abuse, sexual abuse, neglect) | |
No trauma | 0 reported lifetime traumas | |
(Exclusions) | At least one reported combat trauma | |
Combat Interpersonal | Combat only | At least one reported combat exposure and 0 reported interpersonal traumas (e.g., abuse, assault) |
Interpersonal only | 0 reported combat exposures and at least one reported interpersonal trauma (e.g., abuse, assault) | |
Both | At least one reported combat exposure and at least 1 reported interpersonal traumas (e.g., abuse, assault) | |
No trauma | 0 reported lifetime traumas | |
Top Bottom Quartile | Top | Top quartile of cumulative trauma load |
Bottom | Bottom quartile of cumulative trauma load (trauma load > 0 ) | |
No trauma | 0 reported lifetime traumas |
Table 2: Sample size (N), sex and race and average age for samples in each trauma variable category.
Trauma Measure | Trauma Category | N | F | M | AA | EUR | HISP | NT | MDD | PTSD | Avg, Age |
---|---|---|---|---|---|---|---|---|---|---|---|
Trauma Any | Any Trauma | 137 | 70 | 67 | 15 | 121 | 1 | 2 | 31 | 104 | 42.1 |
No Trauma | 167 | 45 | 122 | 35 | 129 | 3 | 92 | 75 | 0 | 48.2 | |
Childhood Adulthood | Childhood Only | 47 | 24 | 23 | 7 | 39 | 1 | 1 | 13 | 33 | 43.8 |
Adulthood Only | 45 | 18 | 27 | 5 | 40 | 0 | 1 | 6 | 38 | 42.2 | |
Both | 22 | 14 | 8 | 2 | 20 | 0 | 0 | 2 | 20 | 39.3 | |
No Trauma | 162 | 45 | 117 | 35 | 124 | 3 | 89 | 73 | 0 | 47.8 | |
Single Complex | Single Only | 17 | 8 | 9 | 0 | 17 | 0 | 0 | 4 | 13 | 41.0 |
Complex Only | 55 | 30 | 25 | 7 | 47 | 1 | 1 | 19 | 35 | 46.1 | |
Both | 45 | 31 | 14 | 3 | 42 | 0 | 0 | 8 | 37 | 38.5 | |
No Trauma | 167 | 45 | 122 | 35 | 129 | 3 | 92 | 75 | 0 | 48.2 | |
Combat Interpersonal | Combat Only | 19 | 0 | 19 | 5 | 14 | 0 | 1 | 0 | 18 | 39.5 |
Interpersonal Only | 99 | 65 | 34 | 10 | 88 | 1 | 1 | 28 | 70 | 42.9 | |
No Trauma | 162 | 45 | 117 | 35 | 124 | 3 | 89 | 73 | 0 | 47.8 | |
Top Bottom Quartile | Top | 34 | 24 | 10 | 1 | 32 | 1 | 0 | 4 | 30 | 41.7 |
Bottom | 35 | 11 | 24 | 7 | 28 | 0 | 2 | 7 | 26 | 41.2 | |
No Trauma | 167 | 45 | 122 | 35 | 129 | 3 | 92 | 75 | 0 | 48.2 |
Multiple correspondence analysis of trauma phenotypes
To determine the level of similarity in the trauma variable categories within our cohort, we ran multiple correspondence analysis (MCA) on the donor trauma profiles using factoMineR package 30. This analysis can be thought of as a generalization of principal component analysis for categorical data and finds the dimensions associated with the largest sources of variation in the data. We plotted each trauma variable category and its association with MCA dimensions to demonstrate the relatedness of our definitions within our cohort.
RNA-seq preprocessing and quality control
RNA transcript counts were log2 transformed and normalized for library size. We removed lowly expressed genes by requiring at least 20 counts per gene in at least 2 samples and transcripts from sex chromosomes and mitochondrial RNA then voom normalized for linear modeling31.
Gene differential expression and trauma-leading gene analysis
We used surrogate variable analysis (SVA)32 to calculate surrogate variables (SVs) that capture measured and latent sources of variation in gene expression for each brain region, while preserving the effects of TraumaCount, sex and diagnosis. We calculated 23, 22, 25 and 28 SVs, respectively, for the DLPFC, dACC, BLA and MeA, and verified that at least one SV was significantly correlated with each of the known covariates (RIN, sequencing batch, PMI, race, and genotype-derived PCs). For each brain region, we corrected for their respective SVs and used residualized count matrices for differential expression analysis.
We calculated differential expression levels for each trauma measure (Table 1) in each brain region using limma33 with residualized expression for each gene as an outcome and trauma variable as a predictor. For sex-interactions, we used an interaction model with residualized expression for each gene as an outcome and an interaction term trauma variable:sex as a predictor including the main effects of trauma variable and sex in the model (Expression ~ trauma x sex + trauma + sex). Differentially expressed genes (DEGs) and sex-interaction DEGs were defined by a nominal p-value cutoff of p <0.05 or an adjusted False Discovery Rate (FDR)<5%.
We next conducted a gene-level sensitivity analysis (Trauma Leading Gene Analysis), which identifies genes for which the variance explained in expression is greatest for trauma vs. sex or diagnosis. For each significant gene association, we determined which variables (PTSD, MDD, and/or sex) were associated with the gene in the same direction as trauma and, of those, which variable explained the most variance in the gene’s expression based on a nested R2 statistic in a joint model of expression (expression ~ trauma + sex + diagnosis) (SFig. 1A).
We conducted gene set enrichment analysis of trauma-leading DEGs that were pre-ranked by association t-score using fgsea34 (R package). We tested for enrichment of a manually curated list of Gene Ontology terms relevant to postmortem neural tissue based on broad categories of terms (GO slims) accessed via QuickGO35. We then tested for overrepresentation of the functional categories among the significant (FDR<5%) GO terms using a binomial exact test.
We used Pearson correlation statistics of gene-trait t-scores to compare transcription profiles across brain regions as a genome-wide measure of concordance. In some cases we visualized the level of concordance/discordance using rank-rank hypergeometric overlap (RRHO) heatmaps where the input score was calculated as −log10(p-value)*sign(effect size) and all tested genes are included using RRHO236(R package).
Cell type-specific expression imputation and differential expression analysis
We deconvolved bulk brain tissue expression to estimate cell type proportions with single cell reference panels for cortex37 or amygdala38 using CIBERSORTx39. Excitatory and inhibitory neuronal subtypes were collapsed into single groups of excitatory neurons and inhibitory neurons. We tested for association of brain cell type proportions as an outcome and trauma variables, sex or diagnosis as a predictor using linear regression, covarying for sampling plate, postmortem interval, age, race and RIN. We then used bMIND40 to impute sample-level cell-type specific gene expression matrices for six brain cell types (excitatory neurons, inhibitory neurons, astrocytes, oligodendrocytes, endothelial cells, and microglia) for DLPFC, dACC, MeA and BLA, and an additional general “neurons” cell type for DLPFC and dACC.
As was done with bulk tissue, we calculated SVs for each cell type for each brain region and residualized cell type expression matrices for the optimum number of SVs as calculated in SVA. We ran differential expression analysis and trauma-leading gene analysis as previously described to obtain cell type DEGs (ctDEGs). FDR multiple testing correction was conducted within cell type within brain region with a 5% FDR significance threshold. Downstream analyses include only those ctDEGs which pass trauma-leading gene criteria.
To test whether some cell type was more responsive to one trauma variable category vs another, we performed a binomial test to assess whether the ratio of DEGs for each trauma type deviated from the proportion observed in bulk tissue samples for each cell type and brain region. P-values were adjusted for multiple comparisons using a FDR, with significance set at FDR<0.05. Adjusted log ratios were calculated by comparing the log ratio of DEGs in cell types to that in bulk tissue.
Hierarchical clustering of transcriptional signatures
Transcriptional signatures were evaluated as gene-level Student’s T scores (logFC normalized by standard error) for genes nominally (p<0.05) significant in at least 1 trauma cdategory signature and included for hierarchical clustering based on Euclidian distances using hclust (method = “complete”). Clusters were then determined by cutting at inflection point of k-cluster Dunn index values (SFig. 4C) between 2 and 10 clusters. Trauma transcriptomic signature cluster- and brain region-associated genes were identified by association of gene-trauma t-scores with cluster identity or brain region vs all other clusters using linear regression.
Gene Co-expression analysis
For coexpression analyses, we corrected gene expression count matrices for known covariates for each brain region41. Using variance partition, we identified factors that explain ≥1% variation in ≥10% of genes for each brain region and residualized out those effects. We then removed genes that are below the bottom 30th percentile of median expression and dispersion (type= “cv”) of expression42. The resulting count matrix was used as input for coexpression module detection and module differential gene correlation analysis.
We analyzed gene co-expression using Multiscale Embedded Gene Co-expression Network Analysis (MEGENA) framework to construct planar filtered networks, cluster into multiscale modules and detect multiscale hubs for each brain region43. We used all samples available for each brain region to construct each multiscale coexpression network. Modules were required to have a minimum of 10 genes and a maximum of half of the genes detected for each brain region.
Modules were annotated for function and cell type based on module member enrichment of GO terms relevant to postmortem brain tissues and neural cell type-specific marker genes44 using the moduleGO function as part of the DGCA R package. The modules were then categorized into the function in which the top GO term belonged and the top cell type based on lowest significant p-value surviving a 5% FDR threshold. If a term was annotated to multiple categories, then the category representing the largest percentage of significant terms was assigned. We then tested for enrichment of trauma DEGs or sex-interacting trauma DEGs in modules using a Fischer’s Exact Test implemented in GeneOverlap R package. We also tested for overrepresentation of functional and cell type groups among trauma DEG-enriched modules using a binomial test where x=number of significant modules in a category X, n=total number of significantly modules and p=proportion of modules in category X of all modules. Binomial p-values<0.05 were considered nominally significant and FDR adjusted q-values<0.05 were considered significantly overrepresented.
Differential gene correlation analysis (DGCA)45 calculates a change in correlation between pairs of genes within a module for two conditions (e.g. trauma vs no trauma), which produces a scaled estimate (ZScoreDiff). We then calculated a median differential correlation (MeDC) value to obtain a module-level estimate of the change in coexpression structure with trauma exposure. For each module and trauma measure, we calculated MeDC values and corrected for multiple testing using a 5% FDR threshold for significance.
Human induced pluripotent stem cell (hiPSC) transduction and treatment
Control hiPSC-derived NPCs (NSB553-S1-1, male, European ancestry; NSB2607-1-4, male, European ancestry) were cultured in hNPC media: DMEM/F12 (Life Technologies #10565), 1x N2 (Life Technologies #17502-048), 1x B27-RA (Life Technologies #12587-010), 1x Antibiotic-Antimycotic, 20 ng/ml FGF2 (Life Technologies) on Geltrex (ThermoFisher, A1413301). hiPSC-NPCs at full confluence (1–1.5×107 cells/well of a 6-well plate) were dissociated with Accutase (Innovative Cell Technologies) for 5 mins, spun down (5 mins X 1000g), resuspended and seeded onto Matrigel-coated plates at 3–5×106 cells/well. Media was replaced every two-to-three days for up to seven days until the next split.
At day −1, confluent hiPSC-NPCs were transduced with rtTA (Addgene 20342) and NGN2 (Addgene 99378) lentiviruses. At day 0 (D0), 1 µg/ml dox was added to induce NGN2-expression. At D1, transduced hiPSC-NPCs were treated with antibiotics to select for lentiviral integration (1 mg/ml G-418). At D3, NPC medium was switched to neuronal medium (Brainphys (Stemcell Technologies, #05790), 1x N2 (Life Technologies #17502–048), 1x B27-RA (Life Technologies #12587–010), 1 µg/ml Natural Mouse Laminin (Life Technologies), 20 ng/ml BDNF (Peprotech #450–02), 20 ng/ml GDNF (Peprotech #450–10), 500 µg/ml Dibutyryl cyclic-AMP (Sigma #D0627), 200 nM L-ascorbic acid (Sigma #A0278)) including 1 µg/ml Dox. 50% of the medium was replaced with fresh neuronal medium once every second day.
On day 5, young hiPSC-NPC NGN2-neurons were replated onto geltrex-coated plates. Cells were dissociated with Accutase (Innovative Cell Technologies) for 5–10 min, washed with DMEM, gently resuspended, counted and centrifuged at 1,000xg for 5 min. The pellet was resuspended in neuron media and cells were seeded at a density of 1.2×106 per well of a 12-well plate.
At D11, iGLUTs were treated with 200 nM Ara-C (Sigma #C6645) to reduce the proliferation of non-neuronal cells in the culture, followed by half medium changes. At D17, Ara-C was completely withdrawn by full medium change. iGLUTs were fed by half medium changes until treated at D21 by a half medium change, with final concentrations of 1000nM HCort (Sigma #H0888), 10nM estradiol (Sigma #E1024), both or DMSO vehicle only. iGLUTs were harvested in trizol 48 hours post treatment.
hiPSC RNA isolation, sequencing and analysis
Samples harvested in trizol were sent to the Yale Center for Genome Analysis for RNA isolation and library prep. Total RNA were run on the bioanalyzer for quality control, then selected for polyadenylated transcripts using oligo-dT beads followed by random priming. Sequencing was run on the Illumina NovaSeq instrument.
The Rsubread package46 was used to align raw reads to the GRCh38 genome assembly and to generate gene expression counts. Transcripts with at least 10 counts per gene in at least 1 sample were kept. Differential expression analyses were done using the limma package33, with voom-normalized counts and a design model including the drug treatment, technical replicate, RIN, RNA concentration, and surrogate variable identified by SVA. The limma::duplicateCorrelation function was applied in order to account for within-donor correlation. Genes with qFDR<0.05 were considered significantly differentially expressed.
RESULTS
Trauma is transcriptionally encoded in the human brain in a region- and cell-type-specific manner
To identify a transcriptional signature of trauma in the postmortem human brain, we first tested for transcriptional associations with trauma exposure (traumaAny) and cumulative trauma burden (traumaCount) as a quantitative measure across four brain regions: DLPLC, dACC, BLA and MeA. Our cohort includes 136 individuals with at least one reported trauma (168 had no reported trauma; SFig. 1A). Gene expression counts from RNA-seq were corrected for surrogate variables preserving the effects of traumaCount, sex and diagnosis and then tested for association with several trauma measures (Table 1; STable 1). We conducted sensitivity analyses to identify significant gene expression associations driven by trauma, rather than diagnosis or sex, termed trauma-leading genes, and only included those for downstream analyses (See SMaterials; SFig. 1).
We identified 4 genes whose expression significantly (pFDR<0.05) changed with increasing traumaCount in the MeA: LMO2 (logFC (per increase in 1 trauma exposure)= −0.034, p=2.2×10−6), ARHGEF18 (logFC=0.010, p=4.1×10−6), ACVR1 (logFC=−0.021, p=4.2×10−6), and SPTLC2 (logFC=0.014, p=7.92×10−6). 143–163 and 439–661 genes were nominally (p < 0.05) associated with traumaAny and traumaCount, respectively, across each of the four brain regions (Fig. 1A & SFig. 2A). Using RRHO analysis, we observed a greater transcriptional concordance between prefrontal cortex regions vs amygdala regions among traumaCount signatures (Fig. 1B). We conducted gene set enrichment analysis of all nominally significant (p<0.05) associations and enrichment of functional categories among those significantly enriched GO terms (STable 2). TraumaAny signatures were enriched in gene regulation terms such as transcription factor binding (GO:0061629, NES=1.97, qFDR= 0.001) in the DLPFC, protein synthesis terms in dACC (GO:0003735, NES=2.71 , qFDR= 3.8×10–11) and BLA (GO:1990904, NES=1.79, qFDR= 2.1×10–4) and spliceosome (GO:0005681 NES= 2.34, qFDR= 4.6×10–6) and mRNA processing (GO: 011441, NES=2.00 , qFDR=4.6×10–6) in MeA. TraumaCount signatures were enriched in immune response terms (downregulated; GO:0002274, NES=−2.2, qFDR=3.0×10–4) in DLPFC, and RNA processing (GO:0006396, NES=1.92, qFDR=4.25×10–8) and ion transmembrane transport (downregulated; GO:0015075, NES=−1.77, qFDR=1.43×10–4) in BLA (Fig.1C–E).
Bulk gene expression analyses represent aggregate measures of cell type-specific expression. To isolate cell type-specific-patterns of trauma-gene associations, we deconvolved cell type proportions and imputed cell type gene expression using single cell RNA sequencing references from postmortem cortical and amygdala tissue 37,38,40. Cell type proportions across brain regions were significantly associated (pFDR < 0.05) with sex and, for 5 brain region cell type-pairs, lowly correlated (r<|0.1|) with MDD diagnosis (SFig. 2B&C). We tested for associations of imputed cell-type expression with traumaany and traumaCount and identified 1–11 and 1–2091 cell-type DEGs (ctDEGs, p<0.001), respectively across regions(STable 3). Oligodendrocytes in dACC (2091 ctDEGs) and MeA (431 ctDEGs) had the largest transcriptional responses to traumaCount. We followed up on our significant MeA traumaCount genes from bulk tissue (Fig. 1A) to identify potential cell types driving their association; LMO2 (p=7.7×10−6) and ARHGEF18 (p=2.1×10−4) associations were strongest in astrocytes and ACVR1 traumaCount association was strongest in neurons (p=1.x10−6) (Fig. 1F).
Trauma disrupts gene coexpression and gene-gene correlations in a brain region-specific manner.
To understand the systems-wide functional impacts of trauma, we used MEGENA to resolve 258, 208, 315, and 320 brain-region specific multiscale coexpression modules for DLPFC, dACC, MeA and BLA, respectively, and annotated each for functional and cell type enrichments (SFig. 3; STable 4). 41% (DLPFC), 37% (dACC), 41% (MeA) and 42% (BLA) of trauma signature genes were within coexpressed networks.. We hypothesized that these genes are coordinated by common regulators and carry out common functions making them ideal as potential therapeutic targets. We tested for enrichment of the traumaany and traumaCount transcriptional signatures in the corresponding brain region-specific co-expression modules (Fig. 2A&B & SFig 4&5; STable 5) and summarized the overrepresentation of neural functional and cell type categories among those enriched coexpressed modules (Fig. 2C & SFig. 5C; STable 6).
Larger-scale modules were significantly enriched with trauma signature genes, and more modules were enriched in traumacount signatures (20–45 modules across brain regions) than traumaany (3–5 modules across brain regions). The BLA had the greatest number of modules enriched in the traumacount signature with an overrepresentation of myelin (qFDR= 7.44×10−3) and oligodendrocyte (qFDR= 3.31×10−3) annotated modules (Fig. 2C). In the MeA, the dichotomous traumaAny signature enriched in blood-brain barrier (BBB) (qFDR= 4.44×10−3) and endothelial modules (qFDR= 2.90×10−2) and the continuous traumacount signature additionally enriched in microglia (qFDR= 0.046) modules. This suggests an overall disruption of MeA BBB function with exposure to any number of traumas and neuroimmune dysregulation with exposure to increasing traumas. Endothelial module 140 of the MeA was significantly enriched for both traumaAny and traumaCount signatures, specifically with genes downregulated with traumaCount such as module hub genes ABCG2 and ESAM (Fig. 2D).
While we may not see changes in a single gene’s expression following trauma, changes in coexpression module connectivity may suggest downstream dysregulation of their shared function. We tested for differential module connectivity, termed differentially correlated modules (DCMs), between samples with any trauma exposure and no reported trauma in each brain region (SFig. 4; STable 7) and tested for enrichment of functional and cell type categories (SFig. 4E; STable 6). TraumaAny DCMs in the DLPFC were enriched for metabolic modules (binomial qFDR=0.049), such as module 224 annotated for neuronal metabolism (Fig. 2E). We found a gain in correlation for MeA module 499, which is annotated for lipid and sterol biosynthesis with hub gene EPT1( aka SELENOI) (SFig. 4F).
Childhood trauma is characterized by amygdala and excitatory neuronal dysregulation
Lifetime traumatic experiences vary considerably on an individual level. The developmental period in which trauma occurs likely contributes to heterogeneity in transcriptional signatures of trauma. We repeated our differential expression and trauma driver analyses for samples from donors with trauma during childhood only (N=47) or adulthood only (N=45) compared to those with no reported trauma (N=162) (STable 1).Childhood trauma had a greater number of amygdala DEGs whereas adulthood trauma had a greater number of prefrontal cortical DEGs with a significant interaction between region and trauma (two-way ANOVA p=0.009) (Fig. 3A). Nominally significant (p<0.05) childhood trauma genes were enriched in ion transmembrane transport in MeA (downregulation; GO:0006812, NES=−1.73, qFDR=1.19×10−4) and BLA (GO:0015075, NES=−1.68, qFDR=2.79×10−3), and histone deacetylation in BLA (GO:0000118, NES=2.14, qFDR=8.05×10−3). Adulthood trauma genes were enriched in RNA processing and telomere lengthening in DLPFC (GO:0006397, NES=1.94, qFDR=1.62×10−4; GO:0010833, NES=2.13, qFDR=1.61×10−3) and MeA (GO:0006396, NES=1.81, qFDR=8.31×10−6) and ribosomal genes in DLPFC and BLA (SFig.6A; STable 2).
Among the imputed cell type trauma DEGs (SFig. 6B), oligodendrocytes in dACC and inhibitory neurons in DLPFC had the greatest number of ctDEGs (p<0.05) in association with both childhood and adulthood trauma. We asked whether certain cell types were more transcriptionally responsive to childhood or adulthood trauma, as measured by a difference in the number of ctDEGs, than expected from bulk tissue DEG abundance. We observed the greatest differences in ctDEGs between childhood and adulthood trauma in the MeA: microglia and endothelial cells had more adulthood trauma ctDEGs, whereas excitatory neurons had more childhood trauma ctDEGs (Fig. 3B). Since limbic regions are not yet fully mature during childhood, we asked whether MeA excitatory neurons dysregulation with childhood trauma correlates with dysregulation observed in hiPSCs-derived NGN2 glutamatergic neurons exposed to HCort28(Fig 3C). As expected, childhood trauma ExN ctDEGs had the greatest overlap (219 concordant genes, Fisher’s exact p=3.2×10−50) with nominally significant HCort DEGs among excitatory neuron ctDEG signatures for traumaAny, childhood or adulthood traumas for each brain region (Fig. 3D). Concordantly regulated genes are shown in Figure 3E.
We tested for enrichment of childhood and adulthood trauma signatures in gene coexpression modules and for differential module connectivity following childhood or adulthood trauma (SFig 7; STable 5&7). Among the significantly enriched modules, DLPFC modules annotated for neurons were overrepresented for both child and adult trauma signatures (SFig. 6C; STable 6). Though fewer MeA modules were significantly enriched in adult trauma, both childhood and adulthood trauma enriched modules shared subthreshold overrepresentations of neuron and BBB modules. Gene coexpression relationships were most disrupted in the MeA; 31 MeA modules were differentially correlated with childhood trauma and 12 MeA modules were differentially correlated with adulthood trauma with the majority of modules gaining connectivity with trauma (Fig. 3F). We did not observe any significant enrichments of functional or cell type categories among MeA DCMs (SFig. 6D).
We hypothesized that some genes may be associated with the accumulation of childhood or adulthood traumas, which may not be captured in the binary variables (Childhood only vs no trauma and adulthood only vs no trauma). We repeated analyses with a continuous variable for cumulative childhood(childhood count) or adulthood traumas(adulthoodcount), and dentified 4 significant childhoodcount DEGs (qFDR<0.05) in the MeA (AIRN, logFC=−0.11, p=6.2×10−9; EML1, logFC=0.04, p=5.0×10−8; STMN4, logFC=0.06, p=1.7×10−6; and LANCL1, logFC=0.03, p=5.6×10−6), one of which (LANCL1, logFC=0.03, p=1.8×10−6) was also significantly associated in the BLA (Fig. 3G; STable 1).
At a transcriptome-wide scale, we observed brain region specificity in the response to childhoodcount compared to adulthoodcount. Of all nominally significant DEGs (p<0.05), the frequency of DEGs across brain regions remained similar to traumaCount, with the exception of nearly double the genes in the DLPFC associated with adulthoodcount (SFig. 8A). Childhoodcount signatures were enriched in cis-golgi (downregulation) in DLPFC, ion transport (downregulation) in MeA and DNA repair in BLA; adulthoodcount signatures were enriched in mRNA processing in the DLPFC and mitochondrial and protein synthesis genes (SFig. 8B; STable 2). Transcriptome-wide correlations across signatures and hierarchical clustering also demonstrated a divergence in the encoding of increasing child and adult traumas. While the childhoodcount signatures largely correlated and clustered with traumaCount, they negatively correlated with (r=−0.18 to r=−0.28) and clustered away from adulthoodcount (SFig. 8C–D).
Among coexpression modules, adulthoodcount signatures were enriched in 60 DLPFC modules with an overrepresentation of neuronal modules (Fig. 3H & SFig. 9A; STable 6). This is in contrast to the 17 DLPFC modules enriched in childhoodcount signatures with an overrepresentation of protein synthesis modules, supporting a strong encoding of adulthood trauma in the DLPFC. In the MeA, childhoodcount and adulthoodcount signatures were largely enriched in similar modules (Fig. 3H), with similar subthreshold overrepresentations in oligodendrocyte and myelin modules (SFig. 9B). However, we identified a significant enrichment of immune/microglia modules (MeA module 6 and child modules 75, 282, 472) in adulthoodcount signatures but not enriched with childhoodcount signatures.
Transcriptomic signatures of trauma differ by trauma type
Transcriptional differences between childhood and adulthood trauma may be a result of differences in the types of traumas children and adult experience. To address this, we repeated our differential expression and downstream analyses (SFig. 10A–C; STable 2) and compared the transcriptional signatures of developmental age (childhood, adulthood, or both) with that of different types of traumas (combat, interpersonal, or both; single acute, complex, or both) and trauma load (high or low trauma). We also dissected phenotypic relationships among trauma variables in this cohort with multiple correspondence analysis (MCA) on donor trauma profiles alone (Table 1–2, Fig. 4A, SFig. 11). Dimension 1 of MCA explains the correspondence of trauma exposed categories from the ‘no trauma’ categories. Dimensions 2 and 3 reveal several clusters of corresponding trauma variable categories for which we have assigned the following identifiers (Fig. 4B): (1) High Load: both childhood and adulthood traumas, both combat and interpersonal traumas, both single and complex traumas and top quartile of trauma categories; (2) Complex: interpersonal only, childhood only and complex only; (3) Adulthood: adulthood only and bottom quartile; (4) Combat: combat trauma only and (5) Single: single acute trauma only.
We then asked whether trauma category transcriptomic signatures were more similar within MCA trauma category clusters or within brain regions using a hierarchical clustering approach (Fig.4C). Based on clustering of transcriptomic associations alone, we identified 7 clusters of trauma type-transcriptional signatures. Clustering revealed patterns of region-specific responses to different dimensions of trauma. In general, MCA trauma profile clusters remained clustered together and separate from other trauma profile clusters at greater heights (h=162.5–171.9); combat transcriptional signatures tended to cluster with adulthood transcriptional signatures. Within MCA trauma profile clusters, transcriptional signatures clustered by brain region (h=126.2–162.4), and then by individual trauma variable categories (h=75.5–112.2). Combat/adulthood traumas signatures demonstrated the greatest transcriptional differences between brain regions compared to other trauma categories. There was one exception to this general pattern: DLPFC transcriptional signatures for adulthood and high load trauma category clusters separated away from dACC and amygdala signatures for those trauma categories (h=174.1). This suggests that exposure to adulthood trauma is encoded similarly in DLPFC regardless of past traumas in childhood.
Using our imputed cell type expression, we asked whether certain cell types were more transcriptionally responsive to specific trauma types (SFig. 10D) and differentially responsive between trauma variable categories (SFig. 10E). While most ctDEGs across brain regions were comparatively enriched for interpersonal traumas, BLA endothelial cells and to a lesser extent, BLA microglial, dACC neurons and MeA oligodendrocytes were more responsive in combat trauma profiles (Fig. 4D).
We next looked at coexpression modules enriched in trauma type transcriptional signatures (STable 7) and their overlap across combat, interpersonal, single, complex, childhood and adulthood, as well as traumaAny. Overall, the majority of modules were either specific to one trauma or enriched for all trauma types, with the exception of a cluster of common modules between interpersonal, complex and childhood traumas. No modules were specific to TraumaAny (Fig. 4E), which suggests that these 6 trauma types reflect the heterogeneity in trauma signatures among coexpressed genes. 32 modules in total (10, 4, 6, and 12 modules in DLPFC, dACC, MeA and BLA), were commonly enriched among all trauma types (Fig. 4E&F). These convergent modules were spread across all 4 brain regions and various functions and cell types (Fig. 4G, SFig.12). Of those modules specific to one trauma type, childhood trauma-specific modules were mostly in dACC (14 modules) (SFig.11, SFig.14A), adulthood-specific modules were split between cortical regions (DLPFC 7, dACC 6), combat-specific modules were greatest in the DLPFC (6 modules)(SFig.14B), interpersonal-specific modules were split among all brain regions (5(MeA)-8(BLA&dACC)), complex-specific modules were greatest in DLPFC and single trauma-specific modules were greatest in MeA (13 modules) (Fig. 4F; SFig. 12). 17 modules were commonly enriched among childhood, interpersonal and complex trauma types: 11 of those were in the BLA annotated with neuronal and metabolic functions, for example, inhibitory synapse assembly (modules 33 and 149) in neurons, and glycoprotein (module 73), carboxylic acid metabolism (module 229) in astrocytes and sterol biosynthesis (module 78) in oligodendrocytes. (Fig.4H).
Convergent sex specific mechanisms of trauma and HCort
Previous studies have demonstrated sex-specific transcriptional alteration with stress-related psychiatric disorders (see Introduction). To identify genes for which the effects of trauma are modulated by sex, we tested for trauma x sex interaction on expression for genes that were nominally significant trauma DEGs (Fig 5A). Of the 25,876 gene-trauma associations tested, 9 associations survived FDR correction and 405 associations (345 unique genes) were nominally significant for trauma-by-sex interaction (SFig. 15A, STable 9), including SLC38A3(interaction beta=−0.18145785, p=0.0003882087) and PPARD (interaction beta=−0.03932737, p=0.0002782924; Fig. 5B&C). To determine whether the 9 significant trauma x sex interactions were driven by specific cell types, we tested their association within imputed cell type expression (SFig. 15B). We identified 7 genes (SLC38A3, PPARD, SNORA46, MIR4292, IL1RN, DLX5, PCNA) for which neurons had the strongest trauma x sex interaction, including SLC38A3 (interaction beta=−0.22, p=0.0002) and PPARD (interaction beta= −0.032, p=0.0063) (Fig. 5D). We tested for enrichment of nominally significant sex-interacting trauma genes in brain region-specific coexpression modules and found 30 module-trauma variable enrichments (pFDR<0.05) across the four brain regions studied (STable 8). Several modules were significantly enriched for genes relatively upregulated in females with interpersonal traumas in dACC and childhood trauma in MeA (Fig. 5E). In the dACC, module 368 was enriched for female-specific childhood trauma and interpersonal trauma genes (interpersonal: OR=537.1, p=1.26×10−5, qFDR= 0.003) and was annotated for astrocytes and with hub genes TLR4, ETNPPL and P2RY1 (Fig. 5F). In the MeA, module 6 was enriched for genes upregulated specifically in females (OR=69.4 p=2.8×10−6, qFDR=8.7×10−4) such as HCG22, CLEC7A, ARHGAP15 and TMC8 and was annotated for immune response and microglia (SFig. 15C).
We next explored potential mechanisms for sexual dimorphism in gene expression with trauma. We asked whether these associations are driven by sex-biases in types of trauma exposure, by exposures to sex-specific hormones or their interaction with stress hormones. To directly test hormonal effects in a cell type-specific manner, we applied HCort, estradiol (E2), and their combination (HCort+E2) to hiPSC-derived NGN2 glutamatergic neurons in vitro and identified 12, 0 and 39 significant (qFDR<0.05) DEGs, and 787, 677, 642 nominally significant (p<0.01) DEGs respectively, for each condition (SFig16A&B).
For significant (qFDR < 0.05) trauma x sex-interacting genes, we compared gene expression associations with different trauma types within this postmortem dataset and with HCort, E2 and HCort+E2 exposure in the NGN2 neuronal cell populations (Fig.5B,SFig. 16C). We highlight 2 genes: SLC38A3 and PPARD. Expression of SLC38A3 in the MeA is specifically decreased in females with trauma exposure (Fig. 5B). sWe observed a similar downregulation of SLC38A3 with interpersonal traumas (logFC=−0.12, p=5.6×10−6), suggesting this sex-interaction may be due to an increased prevalence of interpersonal traumas in females (Fig 5F). PPARD expression in DLPFC was specifically downregulated in females and upregulated in males with increasing childhoodcount(Fig. 5C), with the childhoodcount x sex interaction driven by neurons (Fig 5D). We observed a similar upregulation in iPSC-derived NGN2 neurons treated with only HCort (logFC=0.21, p=0.02), but not when combined with estradiol (HCort+E2; logFC=0.1, p=0.3), which suggests a hormonal mechanism for the observed sex interaction with childhoodcount.
DISCUSSION
We investigated the transcriptional signatures of trauma exposure (traumaany), trauma accumulation (traumacount), traumas at distinct developmental periods (childhood only, adulthood only, childhoodcount, and adulthoodcount), distinct trauma types (combat, interpersonal, complex, and single traumas), and trauma load (high load and low load) across four corticolimbic regions of the postmortem human brain. Using imputed brain-region and cell type-specific signatures, cell type annotation of coexpression modules and hiPSC-derived neuronal populations, we observed dysregulation of each neural cell type and each brain region to at least some aspect of trauma exposure, accumulation or trauma type. Lastly, we tested for sex-specificity of trauma transcriptional regulation and identified potential mechanisms (trauma type and hormonal) driving sexual dimorphism in transcription of each sex-specific trauma gene.
We used a hierarchical clustering approach to compare transcriptional signatures of various trauma types. Generally, we found that transcriptional signatures are more variable between trauma measures than between brain regions. DLPFC signatures remained the most similar across all trauma measures that included an exposure to adulthood trauma. This suggests that the DLPFC remains plastic in its encoding of traumas in adulthood regardless of past childhood trauma experiences. On the other hand, we saw the greatest transcriptional differences between brain regions (MeA, BLA and dACC) for adulthood and combat traumas and greater transcriptional similarity in amygdala and dACC with childhood traumas. Together, this evidence suggests that traumas occurring earlier in life have similar widespread changes in gene expression in the amygdala, but as the frontal cortex and amygdala mature, transcriptional effects of trauma diverge. In other words, the amygdala may encode earlier trauma that persists through the lifespan, whereas the prefrontal cortex remains transcriptionally flexible in response to additional traumas.
This supports current evidence for amygdala involvement in childhood trauma47 and weakened functional connectivity between prefrontal cortex and amygdala as a result of early trauma48–50. Rodent models of early life stress tell a similar story of persistent alteration in amygdala circuitry and function and anxiety-like behaviors even after the stress is removed51–53, with evidence for the MeA in particular being involved in mediating sex differences in responses to early stress 54.
We investigated transcriptional responses of specific neural cell types using imputed cell type expression, providing insights into lasting functional effects at the cellular level. In both cortical regions, we observed elevated inhibitory neuron transcription across several trauma measures (aside from combat trauma with an increased endothelial response in the BLA), which supports the current evidence of gamma-aminobutyric acid (GABA)-ergic dysregulation in chronic stress, depression and PTSD 26,55,56. We similarly found a large transcriptional response of oligodendrocytes particularly in the dACC with most trauma types. Oligodendrocytes and myelination have also previously been implicated in MDD 57, childhood abuse58 and stress pathophysiology59, with impaired myelination induced in mouse prefrontal cortex in response to chronic social stress60
We also observed a relatively larger response of MeA excitatory neuron transcription to childhood trauma compared to adulthood traumas (Fig.3B). Using a hiPSC-derived neuronal model, we identified genes concordantly regulated by childhood trauma and by HCort, a glucocorticoid responsible for systemic recruitment of stress response. Excitatory neurons within the MeA and its circuitry are not yet fully mature during childhood when the trauma occurs; likewise, hiPSCs-derived neurons modeled in vitro are thought to retain an immature state61. The identified concordant genes may reflect persistent transcriptional alterations specific to the GC signaling as a result of childhood trauma. Thus, postmortem brain tissues and hiPSC-derived neural cells make complementary systems to dissect molecular mechanisms of neuropsychiatric disorder risk.
Using gene coexpression network analysis, we further investigated the enrichment of trauma DEGs in multi-scale modules of coexpressed genes and, orthogonally, the impact of trauma in dissolving or strengthening module coregulatory relationships. Across all trauma measures, we observed an enrichment of large-scale modules; generally, gene regulation and synaptic neuronal modules in cortical regions and neuronal, glial and immune modules in amygdala. However, as modules specialize, enrichment of trauma DEGs diverge to different small-scale modules by different trauma types. With our differential gene correlation analyses, we found that coregulatory relationships of MeA modules were most altered by trauma, supporting our differential expression results, though trauma DEG enriched modules and differentially correlated modules were, generally, minimally overlapping. These trauma-associated modules and their central hub genes are ripe for further dissection for dissection of their relationship with mood and anxiety symptoms.
Our study highlights the importance of considering different types of trauma, such as those during distinct developmental periods (i.e., childhood trauma versus adulthood trauma) and trauma type (complex, interpersonal, combat and single acute traumas). While analyses that consider all trauma aggregations yield significant power, we also demonstrate as well that distinct trauma types have distinct transcriptomic impacts that affect different pathways and cell types. Among coexpressed networks of genes, all traumaAny signature enriched modules were shared with at least one trauma type module, suggesting a robust dissection of the heterogeneity encompassed within the traumaAny signature by trauma types. We have previously demonstrated considerable heterogeneity in the genetic predisposition to PTSD based on trauma type, specifically between a military vs civilian cohort16. This approach is increasingly important as we disentangle the heterogeneity of psychiatric diagnoses62.
As stated earlier, postmortem studies have identified substantial sex differences of brain gene expression in PTSD and MDD (see Introduction); and on a population scale, there are sex biases in the prevalence diagnosis of psychiatric diagnoses 5 and in their comorbidities64. Here, we investigated sex-specific transcriptional effects of trauma and found several sex x childhood trauma interactions in MeA, supporting the involvement of MeA in mediating sex differences in response to early stress in rodent studies54.
Since sex is multifaceted and interrelated with gender, we consequently investigated a number of biological and societal factors that may drive sex differences in transcription. First, we considered the role of trauma type and influences of gendered social experiences. We identified solute carrier SLC38A3 (SNAT3), which is involved in glutamate-GABA-glutamine cycling, as being downregulated in females with trauma exposure (traumaAny), but observed a similar downregulation with respect to interpersonal trauma. Women are more likely to experience (and report) sexual traumas whereas men are more likely to experience combat and assault65–67. Even when accounting for trauma type, women are still more likely than men to develop PTSD following sexual trauma 67. Further, levels of social and societal support and their potential to mediate psychopathology differ by trauma type and gender68,69.
We also considered the impacts of estradiol, alone and in concert with hydrocortisone on human induced NGN2 neurons to assess possible contributions of sex hormones in transcriptional responses to stress19,70. The PPARD transcript encodes a peroxisome proliferator-activated receptor (PPAR) which is highly expressed in neurons, astrocytes and glia and linked to the development of anxiety71. DLPFC expression of PPARD was specifically upregulated in males with accumulating childhood trauma compared to that in females. Similarly, this transcript was upregulated with treatment of HCort, but not in the additional presence of E2 in hiPSC-derived NGN2 neurons suggesting a hormonal basis of sex interaction with childhood trauma at a neuronal level. Together, we resolved not only trauma-signatures in a sex-specific manner, but also pinpointed aspects of biological sex which may drive these differences for a subset of our trauma-associated genes.
As with all postmortem studies, identifying transcriptomic signatures of trauma or other exposures requires careful delineation of cause and effect; signatures identified may represent the impact of predisposition to the exposure, diagnosis relating to the exposure, medications taken to alleviate symptoms, or the exposure itself. In the case of trauma, genes identified may represent predisposition to PTSD/MDD, or to trauma itself. For example, volunteering for military service has a genetic component72,73. They may also be associated with diagnoses stemming from trauma, or may reflect medications taken to mitigate symptoms stemming from trauma. We apply two approaches to mitigate this concern. First, we test for PTSD and MDD signatures, and note that these are distinct from (although correlated with) our trauma signatures. However, it is possible that these case/control analyses are underpowered compared to our quantitative trauma analysis, and that analysis of PTSD or MDD severity or symptom domains (e.g., see26) may yield additional gene associations. Second, we apply sensitivity analyses to retain only those gene-trauma associations for which trauma explains the most variance in expression compared to diagnosis (or sex). As such, we are left with fewer genes overall, but those for which we have the highest statistical confidence for association with trauma.
This study, to our knowledge, presents the largest postmortem brain transcriptomic study of psychosocial trauma. We approach trauma as a quantitative trait and dive into the heterogeneity of traumatic events, disentangling common and divergent molecular mechanisms of developmental period and trauma type. Future efforts in brain donation should focus on obtaining trauma histories for all individuals, especially those with no psychiatric diagnoses despite lifetime trauma, to study stress resilience and to reduce confounding factors in postmortem brain transcriptomic studies.
Supplementary Material
ACKNOWLEDGEMENTS
We thank Rebecca Signer, Ada Kepinska, Hannah Young and Kayla Retallick-Townsley for critical feedback on the manuscript. We are grateful to the families who donated to this research.
FUNDING
LMH acknowledges funding from NIMH (R01MH124839, R01MH118278, R01MH125938, RM1MH132648, R01MH136149), NIEHS (R01ES033630), and the Department of Defense (TP220451). JHK acknowledges support from the Clinical Neuroscience Division of the National Center for PTSD (Department of Veterans Affairs). CS acknowledges funding from NIH (F30MH132324). EJN acknowledges funding from NIMH (R01MH129306) and the Hope for Depression Research Foundation.
Funding Statement
LMH acknowledges funding from NIMH (R01MH124839, R01MH118278, R01MH125938, RM1MH132648, R01MH136149), NIEHS (R01ES033630), and the Department of Defense (TP220451). JHK acknowledges support from the Clinical Neuroscience Division of the National Center for PTSD (Department of Veterans Affairs). CS acknowledges funding from NIH (F30MH132324). EJN acknowledges funding from NIMH (R01MH129306) and the Hope for Depression Research Foundation.
Footnotes
CONFLICT STATEMENT
J.H.K. has consulting agreements (less than US$10,000 per year) with the following: Aptinyx, Inc. Biogen, Idec, MA, Bionomics, Limited (Australia), Boehringer Ingelheim International, Epiodyne, Inc., EpiVario, Inc., Janssen Research & Development, Jazz Pharmaceuticals, Inc., Otsuka America Pharmaceutical, Inc., Spring Care, Inc., Sunovion Pharmaceuticals, Inc.; is the co-founder for Freedom Biosciences, Inc.; serves on the scientific advisory boards of Biohaven Pharmaceuticals, BioXcel Therapeutics, Inc. (Clinical Advisory Board), Cerevel Therapeutics, LLC, Delix Therapeutics, Inc., Eisai, Inc., EpiVario, Inc., Jazz Pharmaceuticals, Inc., Neumora Therapeutics, Inc., Neurocrine Biosciences, Inc., Novartis Pharmaceuticals Corporation, PsychoGenics, Inc., Takeda Pharmaceuticals, Tempero Bio, Inc., Terran Biosciences, Inc..; has stock options with Biohaven Pharmaceuticals Medical Sciences, Cartego Therapeutics, Damona Pharmaceuticals, Delix Therapeutics, EpiVario, Inc., Neumora Therapeutics, Inc., Rest Therapeutics, Tempero Bio, Inc., Terran Biosciences, Inc., Tetricus, Inc.; and is editor of Biological Psychiatry with income greater than $10,000.
REFERENCES
- 1.Girgenti M. J., Pothula S. & Newton S. S. Stress and Its Impact on the Transcriptome. Biol. Psychiatry 90, 102–108 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hicks E. M. et al. Integrating genetics and transcriptomics to study major depressive disorder: a conceptual framework, bioinformatic approaches, and recent findings. Transl. Psychiatry 13, 129 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nievergelt C. M. et al. Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. Nat. Genet. 56, 792–808 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tovote P., Fadok J. P. & Lüthi A. Neuronal circuits for fear and anxiety. Nat. Rev. Neurosci. 16, 317–331 (2015). [DOI] [PubMed] [Google Scholar]
- 5.Herman J. P. The neuroendocrinology of stress: Glucocorticoid signaling mechanisms. Psychoneuroendocrinology 137, 105641 (2022). [DOI] [PubMed] [Google Scholar]
- 6.McEwen B. S. et al. Mechanisms of stress in the brain. Nat. Neurosci. 18, 1353–1363 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fenster R. J., Lebois L. A. M., Ressler K. J. & Suh J. Brain circuit dysfunction in post-traumatic stress disorder: from mouse to man. Nat. Rev. Neurosci. 19, 535–551 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rohleder N., Wolf J. M. & Wolf O. T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci. Biobehav. Rev. 35, 104–114 (2010). [DOI] [PubMed] [Google Scholar]
- 9.Feinberg I. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J. Psychiatr. Res. 17, 319–334 (1982). [DOI] [PubMed] [Google Scholar]
- 10.Peter R., H. Synaptic density in human frontal cortex — Developmental changes and effects of aging. Brain Res. 163, 195–205 (1979). [DOI] [PubMed] [Google Scholar]
- 11.Yakovlev P. L. & Lecours A. R. The myelogenetic cycles of regional maturation of the brain. Reg. Dev. Brain Early Life 3–70 (1967). [Google Scholar]
- 12.Nemeroff C. B. Paradise Lost: The Neurobiological and Clinical Consequences of Child Abuse and Neglect. Neuron 89, 892–909 (2016). [DOI] [PubMed] [Google Scholar]
- 13.Teicher M. H., Samson J. A., Anderson C. M. & Ohashi K. The effects of childhood maltreatment on brain structure, function and connectivity. Nat. Rev. Neurosci. 17, 652–666 (2016). [DOI] [PubMed] [Google Scholar]
- 14.Weber D. A. & Reynolds C. R. Clinical Perspectives on Neurobiological Effects of Psychological Trauma. Neuropsychol. Rev. 14, 115–129 (2004). [DOI] [PubMed] [Google Scholar]
- 15.Yehuda R. et al. Post-traumatic stress disorder. Nat. Rev. Dis. Primer 1, 1–22 (2015). [DOI] [PubMed] [Google Scholar]
- 16.Huckins L. M. et al. Analysis of Genetically Regulated Gene Expression Identifies a Prefrontal PTSD Gene, SNRNP35, Specific to Military Cohorts. Cell Rep. 31, 107716 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Jakob J. M. D., Lamp K., Rauch S. A. M., Smith E. R. & Buchholz K. R. The Impact of Trauma Type or Number of Traumatic Events on PTSD Diagnosis and Symptom Severity in Treatment Seeking Veterans. J. Nerv. Ment. Dis. 205, 83–86 (2017). [DOI] [PubMed] [Google Scholar]
- 18.Kelley L. P., Weathers F. W., McDevitt-Murphy M. E., Eakin D. E. & Flood A. M. A comparison of PTSD symptom patterns in three types of civilian trauma. J. Trauma. Stress 22, 227–235 (2009). [DOI] [PubMed] [Google Scholar]
- 19.Li S. H. & Graham B. M. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry 4, 73–82 (2017). [DOI] [PubMed] [Google Scholar]
- 20.Slavich G. M. & Sacher J. Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders. Psychopharmacology (Berl.) 236, 3063–3079 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Daskalakis N. P. et al. Systems biology dissection of PTSD and MDD across brain regions, cell types, and blood. Science 384, eadh3707 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Girgenti M. J. et al. Transcriptomic organization of the human brain in post-traumatic stress disorder. Nat. Neurosci. 24, 24–33 (2021). [DOI] [PubMed] [Google Scholar]
- 23.Jaffe A. E. et al. Decoding Shared Versus Divergent Transcriptomic Signatures Across Cortico-Amygdala Circuitry in PTSD and Depressive Disorders. Am. J. Psychiatry 179, 673–686 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Labonté B. et al. Sex-specific transcriptional signatures in human depression. Nat. Med. 23, 1102–1111 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Logue M. W. et al. Gene expression in the dorsolateral and ventromedial prefrontal cortices implicates immune-related gene networks in PTSD. Neurobiol. Stress 15, 100398 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Mansouri S. et al. Transcriptional dissection of symptomatic profiles across the brain of men and women with depression. Nat. Commun. 14, 6835 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Seney M. L., Glausier J. & Sibille E. Large-Scale Transcriptomics Studies Provide Insight Into Sex Differences in Depression. Biol. Psychiatry 91, 14–24 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Seah C. et al. Modeling gene × environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression. Nat. Neurosci. 25, 1434–1445 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Teicher M. H. & Samson J. A. Childhood Maltreatment and Psychopathology: A Case for Ecophenotypic Variants as Clinically and Neurobiologically Distinct Subtypes. Am. J. Psychiatry 170, 1114–1133 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lê S., Josse J. & Husson F. FactoMineR : An R Package for Multivariate Analysis. J. Stat. Softw. 25, (2008). [Google Scholar]
- 31.Law C. W., Chen Y., Shi W. & Smyth G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Leek J. T., Johnson W. E., Parker H. S., Jaffe A. E. & Storey J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882–883 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Ritchie M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47–e47 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Korotkevich G. et al. Fast gene set enrichment analysis. Preprint at 10.1101/060012 (2016). [DOI] [Google Scholar]
- 35.Binns D. et al. QuickGO: a web-based tool for Gene Ontology searching. Bioinformatics 25, 3045–3046 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Plaisier S. B., Taschereau R., Wong J. A. & Graeber T. G. Rank–rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures. Nucleic Acids Res. 38, e169–e169 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wang D. et al. Comprehensive functional genomic resource and integrative model for the human brain. Science 362, eaat8464 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yu B. et al. Molecular and cellular evolution of the amygdala across species analyzed by single-nucleus transcriptome profiling. Cell Discov. 9, 19 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Newman A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773–782 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Wang J., Roeder K. & Devlin B. Bayesian estimation of cell type–specific gene expression with prior derived from single-cell data. Genome Res. 31, 1807–1818 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Cote A. C., Young H. E. & Huckins L. M. Comparison of confound adjustment methods in the construction of gene co-expression networks. Genome Biol. 23, 44 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.McKenzie A. T., Katsyv I., Song W.-M., Wang M. & Zhang B. DGCA: A comprehensive R package for Differential Gene Correlation Analysis. BMC Syst. Biol. 10, 106 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Song W.-M. & Zhang B. Multiscale Embedded Gene Co-expression Network Analysis. PLOS Comput. Biol. 11, e1004574 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.McKenzie A. T. et al. Brain Cell Type Specific Gene Expression and Co-expression Network Architectures. Sci. Rep. 8, 8868 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.McKenzie A. T., Katsyv I., Song W.-M., Wang M. & Zhang B. DGCA: A comprehensive R package for Differential Gene Correlation Analysis. BMC Syst. Biol. 10, 106 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Liao Y., Smyth G. K. & Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47–e47 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Veer I. M. et al. Evidence for smaller right amygdala volumes in posttraumatic stress disorder following childhood trauma. Psychiatry Res. Neuroimaging 233, 436–442 (2015). [DOI] [PubMed] [Google Scholar]
- 48.Burghy C. A. et al. Developmental pathways to amygdala-prefrontal function and internalizing symptoms in adolescence. Nat. Neurosci. 15, 1736–1741 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Herringa R. J. et al. Childhood maltreatment is associated with altered fear circuitry and increased internalizing symptoms by late adolescence. Proc. Natl. Acad. Sci. 110, 19119–19124 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Rauch S. L., Shin L. M. & Phelps E. A. Neurocircuitry Models of Posttraumatic Stress Disorder and Extinction: Human Neuroimaging Research—Past, Present, and Future. Biol. Psychiatry 60, 376–382 (2006). [DOI] [PubMed] [Google Scholar]
- 51.Arnett M. G. et al. The role of glucocorticoid receptor-dependent activity in the amygdala central nucleus and reversibility of early-life stress programmed behavior. Transl. Psychiatry 5, e542–e542 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ishikawa J., Nishimura R. & Ishikawa A. Early-life stress induces anxiety-like behaviors and activity imbalances in the medial prefrontal cortex and amygdala in adult rats. Eur. J. Neurosci. 41, 442–453 (2015). [DOI] [PubMed] [Google Scholar]
- 53.Malter Cohen M. et al. Early-life stress has persistent effects on amygdala function and development in mice and humans. Proc. Natl. Acad. Sci. 110, 18274–18278 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Walker D. M. et al. Crystallin Mu in Medial Amygdala Mediates the Effect of Social Experience on Cocaine Seeking in Males but Not in Females. Biol. Psychiatry 92, 895–906 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Ghosal S., Hare B. D. & Duman R. S. Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression. Curr. Opin. Behav. Sci. 14, 1–8 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Wang J., Zhao H. & Girgenti M. J. Posttraumatic Stress Disorder Brain Transcriptomics: Convergent Genomic Signatures Across Biological Sex. Biol. Psychiatry 91, 6–13 (2022). [DOI] [PubMed] [Google Scholar]
- 57.Nagy C. et al. Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons. Nat. Neurosci. 23, 771–781 (2020). [DOI] [PubMed] [Google Scholar]
- 58.Tanti A. et al. Child abuse associates with an imbalance of oligodendrocyte-lineage cells in ventromedial prefrontal white matter. Mol. Psychiatry 23, 2018–2028 (2018). [DOI] [PubMed] [Google Scholar]
- 59.Long K. L. P. et al. Regional gray matter oligodendrocyte- and myelin-related measures are associated with differential susceptibility to stress-induced behavior in rats and humans. Transl. Psychiatry 11, 631 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Liu J. et al. Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nat. Neurosci. 15, 1621–1623 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Mariani N., Cattane N., Pariante C. & Cattaneo A. Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers. Transl. Psychiatry 11, (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Marchese S. & Huckins L. M. Trauma Matters: Integrating Genetic and Environmental Components of PTSD. Adv. Genet. 2200017 (2022) doi: 10.1002/ggn2.202200017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Bangasser D. A. & Valentino R. J. Sex differences in stress-related psychiatric disorders: Neurobiological perspectives. Front. Neuroendocrinol. 35, 303–319 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Hicks E. M. et al. Comorbidity Profiles of Posttraumatic Stress Disorder Across the Medical Phenome. Biol. Psychiatry Glob. Open Sci. 100337 (2024) doi: 10.1016/j.bpsgos.2024.100337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Breslau N. et al. Trauma and Posttraumatic Stress Disorder in the Community: The 1996 Detroit Area Survey of Trauma. Arch. Gen. Psychiatry 55, 626 (1998). [DOI] [PubMed] [Google Scholar]
- 66.Olff M. Sex and gender differences in post-traumatic stress disorder: an update. Eur. J. Psychotraumatology 8, 1351204 (2017). [Google Scholar]
- 67.Tolin D. F. & Foa E. B. Sex differences in trauma and posttraumatic stress disorder: A quantitative review of 25 years of research. Psychol. Bull. 132, 959–992 (2006). [DOI] [PubMed] [Google Scholar]
- 68.DiMauro J., Renshaw K. D., Smith B. N. & Vogt D. Perceived Support From Multiple Sources: Associations With PTSD Symptoms. J. Trauma. Stress 29, 332–339 (2016). [DOI] [PubMed] [Google Scholar]
- 69.Zalta A. K. et al. Examining moderators of the relationship between social support and self-reported PTSD symptoms: A meta-analysis. Psychol. Bull. 147, 33–54 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Ter Horst G. J., Wichmann R., Gerrits M., Westenbroek C. & Lin Y. Sex differences in stress responses: Focus on ovarian hormones. Physiol. Behav. 97, 239–249 (2009). [DOI] [PubMed] [Google Scholar]
- 71.Rudko O. I., Tretiakov A. V., Naumova E. A. & Klimov E. A. Role of PPARs in Progression of Anxiety: Literature Analysis and Signaling Pathways Reconstruction. PPAR Res. 2020, 1–15 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Lyons M. J. et al. Do genes influence exposure to trauma? A twin study of combat. Am. J. Med. Genet. 48, 22–27 (1993). [DOI] [PubMed] [Google Scholar]
- 73.Miles M. R. & Haider-Markel D. P. Personality and Genetic Associations With Military Service. Armed Forces Soc. 45, 637–658 (2019). [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.